Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of putative breast cancer antigens using an integrative platform of genomics-driven immunoproteomics.

Proteomics - 1 Aug 2017

Qendro Veneta, Lundgren Deborah H, Palczewski Samuel, Hegde Poornima, Stevenson Christina, Perpetua Laurie, Latifi Ardian, Merriman Jesse, Bugos Grace, Han David K

Abstract excerpt

Recent advances in cancer immuno-therapeutics such as checkpoint inhibitors, chimeric antigen-receptor T cells, and tumor infiltrating T cells (TIL) are now significantly impacting cancer patients in a positive manner. Although very promising, reports indicate no more than 25% of cases result in complete remission. One of the limitations of these treatments is the identity of putative cancer antigens in each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Peptide Fragments

Share to Polymorphism, Single Nucleotide

Share to Receptors, Antigen, T-Cell

Source

Identifiers

PMID: 28665052
DOI: 10.1002/pmic.201600318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of putative breast cancer antigens using an integrative platform of genomics-driven immunoproteomics.PMID 28665052Read ↗

Predicting immunotherapy response through genomicsSemantic proximity Read ↗

The immunopeptidome from a genomic perspective: Establishing immune-relevant regions for cancer vaccine designSemantic proximity Read ↗

Transcriptomics and mutational analysis to screen immunogenic neoantigen peptides and Patient stratification based on immune subtypes for TNBCSemantic proximity Read ↗

Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.Semantic proximity Read ↗

Genomics-Guided Immunotherapy for Precision Medicine in CancerSemantic proximity Read ↗

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerSemantic proximity Read ↗

Applications of Immunogenomics to Cancer.Semantic proximity Read ↗

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationSemantic proximity Read ↗

Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltrationSemantic proximity Read ↗

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinomaSemantic proximity Read ↗

Bioinformatics for Cancer Immunotherapy.Semantic proximity Read ↗

MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.